Atlas Trials

Prognostic Impact of Programmed Death Ligand-1 Expression in Advanced Endometrial Cancer

Clinical trial NCT02987777 · COMPLETED

Trial details

NCT number
NCT02987777
Sponsor
Institut de Cancérologie de Lorraine
Status
COMPLETED
Study type
OBSERVATIONAL
Endometrial Cancer
Start date
2016-01-01
Primary completion
2016-08-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.